ADAM17 and heart failure: In contrast, sACE2 activity was shown to be increased in patients with heart failure and correlated with disease severity (20), in which authors hypothesized that cleavage of mACE2 and shedding as sACE2 into the blood circulation through the pathological up-regulation of ADAM17 results in a relative decrease in mACE2 levels and cardiac dysfunction.